A 2015 analyze in the Journal of Weight problems & Metabolic Syndrome addresses widespread adverse activities and significant side effects of anti-being overweight drugs, including phentermine/topiramate that require monitoring, which include metabolic acidosis, urolithiasis, acute angle closure glaucoma, and teratogenic consequences ( eighteenQsym